Search results
Results from the WOW.Com Content Network
Non-scrotal patch: 2.5–15 mg/day Testoderm: Scrotal patch: 4–6 mg/day Axiron: Axillary solution: 30–120 mg/day Androstanolone (DHT) Andractim: Gel: 100–250 mg/day Rectal: Testosterone: Rektandron, Testosteron b: Suppository: 40 mg 2–3×/day Injection (IM Tooltip intramuscular injection or SC Tooltip subcutaneous injection) Testosterone
Testosterone can be taken by a variety of different routes of administration. [2] [3] These include oral, buccal, sublingual, intranasal, transdermal (gels, creams, patches, solutions), vaginal (creams, gels, suppositories), rectal (suppositories), by intramuscular or subcutaneous injection (in oil solutions or aqueous suspensions), and as a subcutaneous implant.
There are several artificial androgens, many of which are manipulations of the testosterone molecule referred to as anabolic-androgenic steroids. Androgen replacement is administered by patch, tablet, capsule, cream or gel; or depot injections given into fat or muscle. [18]
Testosterone (T) is a medication and naturally occurring steroid hormone. [9] It is used to treat male hypogonadism, gender dysphoria, and certain types of breast cancer. [9] [10] It may also be used to increase athletic ability in the form of doping. [9]
Relative affinities of anabolic steroids and related steroids; Steroid Chemical name Relative binding affinities (%) PR Tooltip Progesterone receptor AR Tooltip Androgen receptor ER Tooltip Estrogen receptor GR Tooltip Glucocorticoid receptor MR Tooltip Mineralocorticoid receptor SHBG Tooltip Sex hormone-binding globulin CBG Tooltip ...
Template:Androgen/anabolic steroid dosages for breast cancer; Template:Androgen replacement therapy formulations and dosages used in men; Template:Medications and dosages used in hormone therapy for transgender men; Template:Clinical dosage ranges of oral and injectable androgens and anabolic steroids
The patch was granted a license from the European Medicines Agency in July, and is available on Britain's National Health Service from March 2007. [citation needed]However, in December 2004 the United States the 14-member Food and Drug Administration (FDA) advisory committee, plus voting consultants, for Reproductive Health Drugs unanimously rejected Procter and Gamble's fast-track request for ...
The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). [ 10 ] [ 5 ] It has strong androgenic effects and moderate anabolic effects, which make it useful for producing masculinization and suitable for androgen ...